Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON46577Active, not recruiting
Open-label, single-arm trial of tissue-plasminogen activator in ischemic stroke, sponsored by Gelre ziekenhuizen. Primary endpoints: Feasibility and logistics inventory leading to go/no-go decision, Missed eligible patients and 15 more. Started Dec 2018; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON46577.